Myelofibrosis News and Research

RSS
Genetic testing of chronic neutrophilic leukemia reveals presence of new mutation in patients

Genetic testing of chronic neutrophilic leukemia reveals presence of new mutation in patients

MD Anderson professor to receive award for clinical research excellence at AACR meeting

MD Anderson professor to receive award for clinical research excellence at AACR meeting

LLS, The Myeloproliferative Neoplasm Research Foundation issue MF Challenge Grant

LLS, The Myeloproliferative Neoplasm Research Foundation issue MF Challenge Grant

Study provides new insight on cancer prevention

Study provides new insight on cancer prevention

CTI initiates enrollment in pacritinib Phase 3 trial for myelofibrosis

CTI initiates enrollment in pacritinib Phase 3 trial for myelofibrosis

Studies examine current treatment standards for patients with clotting disorders

Studies examine current treatment standards for patients with clotting disorders

Sanofi announces new data from SAR302503 Phase II trial on myelofibrosis

Sanofi announces new data from SAR302503 Phase II trial on myelofibrosis

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

Longer looks: People with mental disabilities have a vote; Genome sequencing raises hope - also anxiety

Longer looks: People with mental disabilities have a vote; Genome sequencing raises hope - also anxiety

Tool reveals myeloproliferative neoplasm patient burden

Tool reveals myeloproliferative neoplasm patient burden

Researchers reduce life-threatening complication of stem cell transplants in mice with leukemia

Researchers reduce life-threatening complication of stem cell transplants in mice with leukemia

Novartis receives EC approval for Jakavi to treat myelofibrosis

Novartis receives EC approval for Jakavi to treat myelofibrosis

Researchers uncover protein structure that regulates blood cell formation and activity

Researchers uncover protein structure that regulates blood cell formation and activity

Maraviroc reduces incidence of GvHD in blood cancer patients after bone marrow transplantation

Maraviroc reduces incidence of GvHD in blood cancer patients after bone marrow transplantation

Infinity voluntarily stops saridegib Phase 2 trial for chondrosarcoma

Infinity voluntarily stops saridegib Phase 2 trial for chondrosarcoma

CTI acquires world-wide rights to S*BIO’s pacritinib

CTI acquires world-wide rights to S*BIO’s pacritinib

CTI first quarter net loss decreases 66% to $17.4 million

CTI first quarter net loss decreases 66% to $17.4 million

Ruxolitinib boosts QOL and survival for patients with myelofibrosis

Ruxolitinib boosts QOL and survival for patients with myelofibrosis

NEJM publishes results from two Jakafi Phase III studies on MF

NEJM publishes results from two Jakafi Phase III studies on MF

New data from Infinity saridegib and gemcitabine Phase 1b/2 combination trial on pancreatic cancer

New data from Infinity saridegib and gemcitabine Phase 1b/2 combination trial on pancreatic cancer